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<ABSTRACT> 
Crosstalk between Hedgehog and Wnt Pathways  
in Gastric Cancer Cell Differentiation 
Jie-Hyun Kim 
Department of Medicine 
The Graduate School, Yonsei University 
(Directed by Professor Yong Chan Lee)  
Gastric cancer has different biological behaviors to the histological type. 
Thus, the different histological growth patterns of gastric cancers may 
involve the activation of distinct signaling pathways necessary for the 
growth and survival of cancer cells. This study investigated the 
differentiation-specific signal changes between hedgehog (Hh) and Wnt 
signaling pathways in AGS and MKN-45 gastric cancer cells, and HT-29 
colon cancer cells were used as positive controls for differentiation in 
vitro. Differentiation was induced by sodium butyrate and all-trans 
retinoid acid. Sonic hedgehog (SHh), patched (Ptc)-1, and glioma-
associated oncogene (Gli)-1 were analyzed for Hh signaling, and nuclear 
β-catenin was analyzed for Wnt signaling. Paraffin-embedded tissues 
from human gastric cancers were used to evaluate the expression of SHh, 
Gli-1, and β-catenin in vivo. Secreted frizzled-related protein (sFRP)-1 
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was analyzed as a regulator between Hh and Wnt signaling. As results, 
expression of Hh signaling was increased during differentiation. In 
contrast, the expression of Wnt signaling was decreased during 
differentiation. Ectopic expression of Gli-1 increased the level of the 
sFRP-1 transcript, whereas the inhibition of Gli-1 reduced the level of the 
sFRP-1 transcript. Chromatin immunoprecipitation assay indicated that 
Gli-1 was involved in the transcriptional regulation of sFRP-1. Ectopic 
expression of Gli-1 decreased the expression of nuclear β-catenin, and 
the inhibition of Gli-1 recovered the level of nuclear β-catenin. SHh- and 
Gli-1-positive immunoexpression was higher in well differentiated than 
in poorly differentiated tissues. However, nuclear β-catenin-positive 
immunoexpression was lower in well differentiated compared to poorly 
differentiated tissues. In conclusion, the activation of the Hh pathway and 
suppression of the Wnt pathway by Hh signaling occurred during gastric 
cancer cell differentiation. It is suggested that the analysis of 
differentiation-specific signal changes, combined with signals related to 
the process of tumor progression or migration, may be a clue in 
discovering the molecular heterogeneity of gastric cancers. 
---------------------------------------------------------------------------------------- 
Key words: Differentiation, Hedgehog, Wnt, carcinogenesis, crosstalk  
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Jie-Hyun Kim 
Department of Medicine 
The Graduate School, Yonsei University 
(Directed by Professor Yong Chan Lee) 
 
I. INTRODUCTION 
 
Recent evidences suggest that the accumulation of genetic and/or 
epigenetic alterations in multipotent adult stem cells and/or their early progeny 
may contribute to their oncogenic transformation into tumorigenic and 
migrating cancer progenitor cells.1-5 These cancer progenitor cells, also known 
as cancer stem cells or cancer-initiating cells, can give rise to more 
differentiated cancer cell phenotypes in vitro and in vivo, and appear to play key 
roles in tumor formation, progression, and metastasis to distant sites.5 
According to this theory, the activation of specific oncogenic cascades in 
cancer-initiating cells during cancer initiation and progression could result in 
either highly or weakly invasive cancer subtypes.5  
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     Generally, gastric cancers are believed to have different biologic 
behaviors according to their histological type. For example, histologically 
poorly differentiated growth type cancers, according to the World Health 
Organization (WHO) classification, have more aggressive behaviors than 
histologically well and moderately differentiated growth types. Thus, the 
histological type is one of the determining factors in the clinical therapeutic 
approach. Based on cancer-initiating cell theory, the different histological 
growth types of gastric cancer may involve the activation of distinct signaling 
pathway(s) necessary for the growth and survival of cancer cells. 
     The Hedgehog (Hh) and Wnt pathways are representative positive 
regulators for cancer-initiating cells. In Hh signaling, secreted Hh molecules 
[three mammalian hh genes: Sonic, Indian, and Desert hedgehog (SHh, IHh, 
and DHh, respectively)] bind to patched (Ptc; Ptc-1 and Ptc-2) receptors, 
alleviating Ptc-mediated suppression of smoothened (Smo), a putative seven-
transmembrane protein. Smo signaling triggers a cascade of intracellular events, 
leading to activation of a pathway through glioma-associated oncogene (Gli)-
dependent transcription.6 In Wnt signaling, the signal-transducing components 
of the Wnt receptor are members of the low-density lipoprotein receptor-related 
protein (LRP) and Frizzled protein families.6 In the absence of signal 
stimulation, β-catenin protein is destabilized by a cytoplasmic complex 
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containing the proteins Axin, adenomatous polyposis coli (APC), and glycogen 
synthase kinase-3β (GSK-3β).6 Wnt signaling stabilizes β-catenin, which acts as 
a transcriptional co-activator by associating with the TCF/LEF family of 
transcription factors.6  
     These signaling pathways are necessary for the growth and survival of 
cancer cells. Activation of Hh or Wnt signaling has been implicated in the 
development of gastric cancer in many studies.7-17 However, the association 
between the activation of these signals and the histological growth types of 
gastric cancer has been inconsistent.16, 18-20 The discrepancy is probably due to 
the different proportion of cancer stages in each study and no consideration of 
signal interaction(s). Because the histological type or differentiation of gastric 
cancer can be altered by tumor invasion, morphological and phenotypic shifts 
could occur in the process of tumor progression.21, 22 Furthermore, a molecular 
link between Hh and Wnt signaling has been reported.18, 23-25 Thus, an in vitro 
differentiation model by human gastric cancer cell lines was used to investigate 
differentiation-specific signaling changes between Hh and Wnt signaling in 
gastric cancer cells. The analysis of changes in differentiation-specific signals in 
gastric cancer may help in understanding the heterogeneity of gastric cancers. 
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II. MATERIALS AND METHODS 
 
1. Tumor samples and immunohistochemistry 
Stored surgical specimens obtained from 20 patients with gastric cancer were 
used. All cases were provided by the Gastrointestinal Tumor Working Group 
Tissue Bank, Yonsei University Medical Center, Seoul, Korea, between 
December 1996 and December 2004. Authorization for the use of these tissues 
for research purposes was obtained from the Institutional Review Board of 
Yonsei University Health System. The 10 specimens were well differentiated 
adenocarcinoma, and the others were poorly differentiated adenocarcinoma.  
Tissue sections in microslides were deparaffinized with xylene, dehydrated in 
serial dilutions of alcohol, and immersed in 3% H2O2
. 
Following antigen 
retrieval in citrate buffer (pH 6.0), the tissue sections were incubated with 
protein blocking agent (Immunotech, Coulter, Inc., Marseille, France) to block 
nonspecific antibody binding for 20 minutes at room temperature and then 
incubated overnight at 4°C with respective primary polyclonal goat antibodies 
against human SHh (clone H-160) (Santa Cruz Biotechnology, Santa Cruz, 
California, USA), Gli-1 (clone H-300) (Santa Cruz), and β-catenin (clone E-5) 
(Santa Cruz). After washing with phosphate buffered saline (PBS) three times, 
the sections were incubated with a biotinylated secondary antibody (goat anti-
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rabbit IgG, Immunotech) and streptavidin conjugated to horseradish peroxidase 
(Immunotech) for 20 minutes at room temperature, followed by a PBS wash. 
The chromogen was developed for five minutes with liquid 3, 3′-
diaminobenzidine (Immunotech). Next, slides were counterstained with Meyer's 
hematoxylin. Expression status was quantified by scoring both the intensity and 
proportion of SHh, Gli-1, and β-catenin staining. The intensity of cytoplasmic 
SHh staining was scored as 0, negative (weak or similar to background); 1, 
weak (less intense than normal cells); 2, moderate (similar intensity to normal 
cells); and 3, strong (stronger than normal cells).26 The intensity of Gli-1 and β-
catenin staining was scored as 0, no detectable nuclear staining; 1, weak nuclear 
staining; and 2, strong nuclear staining.27 The proportion of expression in each 
tissue was determined by counting positively stained cancer cells in relation to a 
total of three hundred cells, and expressing the result as a percentage.  
2. Cell culture and induction of differentiation  
AGS (ATCC CRL 1739, poorly differentiation), MKN45 (KCLB 80103, 
poorly differentiation) for gastric cancer cells and HT-29 (ATCC HTB38) for 
colon cancer cells were maintained in RPMI 1640 medium (Gibco, Grand 
Island. NY, USA) supplemented with 10% fetal bovine serum (Gibco) and 1% 
penicillin-streptomycin sulfate (Gibco). All cultures were maintained in a 37°C 
incubator supplemented with 5% CO2. Exponentially growing cells were 
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trypsinized and seeded into 10 cm2 cell culture Petri dishes at a density of 
5x106cells/cm2 for AGS, and MKN-45, and HT-29 cells were as positive control 
for induction of cell differentiation. When cells reached 50-70% confluency as 
determined by microscopic examination, medium was renewed and drugs were 
added from concentrated stock solutions. For drug-induced cell differentiation, 
sodium butyrate (NaBU) (Sigma, Munich, Germany) and all-trans retinoic acid 
(Sigma) was used at a final concentration of 1-3 µM for 48hrs. 
Alkaline phosphatase (ALP) activity was determined as markers for 
differentiation. For ALP activity, cell lysates were assayed using 7 µM p-
nitrophenylphosphate as substrate and 2-amino-2-methylpropan-1-ol as solvent.  
To determine ALP activity, the product (p-nitrophenol) produced per minute 
was measured and normalized for cellular protein.28 Carcinoembryonic antigen 
(CEA) was also detected by reverse transcription-polymerase chain reaction 
(RT-PCR) and western blotting as a marker for differentiation.22, 29 Furthermore, 
the expression of Brahma (Brm), which is lost in poorly differentiated gastric 
cancer in vivo,30 was analyzed by RT-PCR and western blot analysis in gastric 
cancer cells after NaBU treatment.  
3. Reverse transcription-polymerase chain reaction (RT-PCR)  
Total RNA was extracted from cultured cells using an RNeasy mini kit 
(Qiagen, Tokyo, Japan). The RNA was reverse transcribed using oligo (dT) 
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primers and SuperscriptTM Ⅱ reverse transcriptase (Invitrogen, Carlsbad, CA, 
USA). PCR was performed with a PCR Maxi kit (iNtRON, Sungnam, Korea) 
according to the manufacturer's instructions. Amplification conditions included 
denaturation at 95°C for 5 min, followed by 30 cycles of 30 sec each at 95°C, 
57°C, and 72°C for SHh, 32 cycles of 45sec each at 95°C, 55°C, and 72°C for 
CEA, 32cycles of 45 sec each at 95°C, 58°C, and 72°C for Brm, 30 cycles of 30 
sec each at 95°C, 55°C, and 72°C for sFRP-1, and 18 cycles of 30 sec each at 
95°C, 60°C, and 72°C for β-actin. PCR products were separated in 1.5% 
agarose gels. The oligonucleotide primers used for RT-PCR were as follows: 
human SHh, 5'-GAG ATG TCT GCT GCT AGT CC-3' and 5'-GTT TCT GGA 
GAT CTT CCC TT-3'; CEA, 5'-CCA GAA CGT CAC CCA GAA TG-3' and 5'-
GGT TCA GAT TTT CCC CTG GA-3'; Brm, 5'-CTG CAA GAG CGG GAA 
TAC AGA CTT CAG GCC CG-3' and 5'-GGC TGC CTG GGC TTG CTT GTG 
CTC CCA AAC C-3'; sFRP-1, 5'-TCA TGC AGT TCT TCG GCT TC-3' and 5'-
CCA ACT TCA GGG GCT TCT TC-3'; β-actin, 5'-TTG CCG ACA GGA TGC 
AGA AGA-3' and 5'-AGG TGG ACA GCG AGG CCA GGA T-3'. 
4. Western blot analysis 
Prepared cells were harvested after washing with PBS. Collected cells were 
lysed with buffer (50 mM Tris-Cl (pH 7.5), 150 mM NaCl, 1 mM EDTA (pH 
8.0), 1% Triton X-100, 1 mM PMSF, 1 mM Na3VO4, and protease inhibitor 
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cocktail (Roche Molecular Biochemicals, Indianapolis, IN, USA)). 
Fractionation was performed by sequential extraction of cytosolic and nuclear 
proteins in non-ionic detergent for analysis of β-catenin. The same amount of 
protein was boiled at 95°C after adding SDS sample buffer (62.5 mM Tris-Cl 
(pH 6.8), 2% sodium dodecyl sulfate, 10% glycerol, β-mercaptoethanol, and 
0.002% bromophenol blue). Samples were loaded in 12% SDS-PAGE gels for 
SHh, sFRP-1, 10% SDS-PAGE gels for CEA, β-catenin, 8% SDS PAGE gels 
for Ptc-1, Gli-1, and 6% SDS-PAGE gels for Brm, and then transferred to 
PVDF membranes (Amersham Biosciences, Pisctaway, NJ, USA).  
Rabbit anti-SHh (Santa Cruz), anti-Gli1 (Santa Cruz), anti-Ptc-1 (Santa Cruz), 
anti-Brm (Santa Cruz), anti-sFRP1 (Santa Cruz), anti-CEA (Upstate 
Biotechnology, Lake Placid, NY, USA) and anti-β-catenin (Santa Cruz) were 
used as the primary labeling antibodies and the appropriate horseradish 
peroxidase–conjugated antibodies (Santa Cruz) were used as secondary 
antibodies. An enhanced chemiluminescence detection system (ECL-Plus, 
iNtRON, Seoul, Korea) was used for detection according to the manufacturer’s 
protocol.  
5. Vectors  
pcDNA3.1/SRα-Gli1 and pcDNA3.1 were kindly provided by Dr. Ishii 
(Tsukuba Life Science Center, Ibaraki, Japan). pSG5-HA/β-catenin and pSG5-
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HA were kindly provided by Prof. Kim (Department of Biochemistry and 
Molecular Biology, Yonsei university college of medicine, Seoul, Korea). 
pTopflash and pFopflash were also kindly provided by Prof. Ryu (National 
Research Laboratory of Tumor Virology and Department of Biochemistry, 
Yonsei university, Seoul, Korea). Cells were plated onto 6-well plates 24hrs 
before transfection and transfected with 2 µg of plasmid using Lipofectamine 
2000 Reagent (Invitrogen) according to the manufacturer’s instructions. Cells 
were treated by NaBU for 24hrs, and then transfected. Forty-eight hours after 
transfection, cells were harvested and subjected to further examination. 
6. RNA interference 
Small interfering RNA (SiRNA) against Gli-1 and negative-control siRNA 
was kindly provided by Dr. Ishii (Tsukuba Life Science Center, Japan). Cells 
were transfected with 100nM siRNA using TransIT-TKO transfection Reagent 
(Mirus, Madison, WI, USA) according to the manufacturer’s instructions. Forty-
eight hours after transfection, cells were harvested and subjected to further 
evaluations.  
7. Luciferase reporter assay 
  Cells grown in 6-well tissue-culture plates were transfected with 2 μg of 
pTopflash and pFopflash, 2 μg of pcDNA3.1 (internal control), 2 or 3 μg of 
gene expression plasmid, and 50 μg of Renilla TK-plasmid. Luciferase assays 
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were performed 48 hours after transfection using a Dual-Luciferase Reporter 
Assay System (Promega, Madison, Wisconsin, USA) according to the 
manufacturer’s instructions.  
8. Chromatin immunoprecipitation (ChIP) assay  
ChIP analysis was done using ChIP assay kit (Upstate Biotechnology, Inc.) 
according to the manufacturer’s instruction. AGS cells were used, and 
immunoprecipitation was done overnight at 4˚C with 10 µl of the sample used 
as the “input,” or 1 µg of Gli-1 or the negative control mouse IgG, positive 
control anti-RNA polymerase beads. After reverse crosslinking, DNA was 
purified with QIAquick PCR purification kit (Qiagen, Valencia, California, 
USA) from the immunoprecipitates. PCR was performed with 35 cycles of 
96 °C for 30 s, 55 °C for 45 s, and 72 °C for 45 s using the following primers 
flanking the putative Gli-binding sites in the human sFRP-1 promoter: sFRP-
1 sense, 5`-GTTGGAGCTGTTTGCTGTGA- 3`; sFRP-1 anti-sense, 5`- ATG
TTTTGGCTTTCCACACC-3`. 
9. Statistical analysis 
Statistical analyses were conducted using Student t-test for luciferase assay 
and Pearson's chi-square test for immunohistochemistry. A two-sided P-value of 
less than 0.05 was considered statistically significant. All statistical analyses 
were performed using SPSS software (SPSS 12.0, Chicago, IL, USA). 
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III. RESULTS 
 
1. Hh and Wnt signaling in human tissues 
To investigate Hh and Wnt signal expression in human gastric cancer 
tissues, immunohistochemical staining was performed for 20 paraffin-embedded 
surgical specimens: 10 well differentiated and 10 poorly differentiated 
adenocarcinomas. All specimens were obtained from patients with American 
Joint Committee on Cancer (AJCC) TNM stage I or II. 
     The samples of well differentiated adenocarcinomas displayed 
higher SHh and Gli-1 staining than those of poorly differentiated 
adenocarcinomas (P < 0.05; Table 1, 2, Fig. 1A, B). In contrast, the 
percentage of cells with nuclear staining for β-catenin was higher in 
poorly differentiated than in well differentiated adenocarcinomas (P < 
0.05; Table 3, Fig. 1C). These findings suggest that Hh signaling 
components are expressed in well differentiated adenocarcinomas at a 
higher level than in poorly differentiated adenocarcinomas. The Wnt 
signaling pathway showed the reverse result. 
 
Table 1. Relationship between sonic hedgehog expression1 and differentiation in 
gastric cancer  
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 Expression intensity of SHh (%)2 
 0 1 2 3 P value* 
WD  15.5 6.9 32.2 45.4 <0.05 
PD  10.0 26.8 44.5 18.7  
SHh, sonic hedgehog; WD, well-differentiated; PD, poorly-differentiated 
* Pearson's chi-square test 
1The proportion of expression in each tissue was determined by counting 
positively stained cancer cells in relation to a total of three hundred cells, and 
expressing the result as a percentage. 
2The intensity of cytoplasmic SHh staining was scored as 0, negative (weak or 
similar to background); 1, weak (less intense than normal cells); 2, moderate 
(similar intensity to normal cells); and 3, strong (stronger than normal cells). 
 
Table 2. Relationship between glioma-associated oncogene expression1 and 
differentiation in gastric cancer  
 Expression intensity of Gli-1 (%)2 
 0 1 2 P value* 
WD  41.1 39.4 19.5 <0.05 
PD 55.2 32.8 12.0  
Gli-1, glioma-associated oncogene; WD, well-differentiated; PD, poorly-
differentiated 
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* Pearson's chi-square test 
1The proportion of expression in each tissue was determined by counting 
positively stained cancer cells in relation to a total of three hundred cells, and 
expressing the result as a percentage. 
2The intensity of Gli-1 staining was scored as 0, no detectable nuclear staining; 
1, weak nuclear staining; and 2, strong nuclear staining. 
 
Table 3. Relationship between nuclear β-catenin expression1 and differentiation 
in gastric cancer  
 Expression intensity of β-catenin (%)2 
 0 1 2 P value* 
WD  49.1 38.2 12.7 <0.05 
PD 27.3 55.0 17.7  
WD, well-differentiated; PD, poorly-differentiated 
* Pearson's chi-square test 
1The proportion of expression in each tissue was determined by counting 
positively stained cancer cells in relation to a total of three hundred cells, and 
expressing the result as a percentage. 
2The intensity of β-catenin staining was scored as 0, no detectable nuclear 
staining; 1, weak nuclear staining; and 2, strong nuclear staining. 
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A. (a) SHh, WD                      (b) SHh, PD 
B. (a) Gli-1, WD                      (b) Gli-1, PD 
 
  
 
 
 
C. (a) β-catenin, WD                   (b) β-catenin, PD 
Fig. 1. Immunohistochemical staining for sonic hedgehog (SHh), glioma-
associated oncogene-1 (Gli-1), and β-catenin in well-differentiated (WD) and 
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poorly-differentiated (PD) gastric carcinoma tissues (x400). Cytoplasmic SHh 
and nuclear Gli-1 staining revealed stronger expression in WD than PD tissues. 
On the contrary, the expression of nuclear β-catenin was stronger in PD than 
WD tissues.  
2. Differentiation of gastric cancer cells  
Poorly differentiated gastric cancer cell lines (AGS and MKN-45) were 
treated with NaBU and RA, well-known differentiation-inducing agents. HT-29 
colon cancer cells were also differentiated with NaBU as a positive control. ALP, 
CEA, and Brm were used as differentiation markers. ALP is a well characterized 
marker of cell differentiation. In this study, increased ALP activity was noted in 
NaBU-treated AGS and MKN-45 cells, in a pattern similar to that in HT-29 
cells (Fig. 2A). Maximal ALP activity was found in gastric cancer cells treated 
with 2 µM NaBU, consistent with a previous study.32 ALP activity also 
increased in gastric cancer cell line after treatment with another differentiation-
inducing agent, RA (Fig. 2B). The expression of CEA and Brm increased in 
gastric cancer cells after NaBU treatment (Figs. 3, 4). These findings suggest 
that gastric cancer cells can be differentiated by differentiation-inducing agents 
(NaBU, RA). Furthermore, differentiated gastric cancer cells over-expressed 
Brm, a valid marker for well differentiated gastric cancer in human tissues. 
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A. 
 
B.  
 
 
 
 
 
 
Fig. 2. Increased alkaline phosphatase activity by differentiaion.  
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A. Sub-confluent AGS, MKN-45 and HT-29 cells were treated with sodium 
butyrate (0-3 µM) for 48 hours. ALP activity was increased in AGS and MKN-
45 cells as similar pattern of the HT-29 cells.  
B. Sub-confluent AGS cells were treated with all-trans retinoic acid (0-3 µM) 
for 48 hours. ALP activity was increased after 1 µM retinoid acid treatment. 
ALP, alkaline phosphatase; RA, all-trans retinoid acid.               
A. (a)                               (b)                                                                         
 
 
B. (a)                               (b) 
 
 
Fig. 3. Overexpression of carcinoembryonic antigen by butyrate treatment in 
AGS (A) and MKN-45 (B) cells.  
RT-PCR (a) and Western blot (b) for CEA were performed with β-actin as 
internal standard. CEA, carcinoembryonic antigen.  
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Fig. 4. Overexpression of Brm by butyrate treatment in AGS (A) and MKN-45 
(B) cells. RT-PCR (a) and Western blot (b) for Brm were performed with β-actin 
as internal standard. 
3. Hh signaling pathway in gastric cancer cell differentiation 
To evaluate the Hh signaling pathway during gastric cancer cell 
differentiation, it was first examined whether the expression of SHh changed in 
gastric cancer cells after NaBU treatment using RT-PCR and Western blot 
analyses. NaBU was treated to 2µM, because gastric cancer cells were 
maximally differentiated in 2µM of NaBU in our study. 
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The expression of SHh increased in AGS and MKN-45 cells during 
differentiation by sodium butyrate (Fig. 5). It was next examined ligand-
dependent Hh signal pathway activation in gastric cancer cells after NaBU 
treatment, according to Gli-1 and Ptc-1, using Western blotting. Over-
expression of Gli-1 and Ptc-1 proteins was noted in both gastric cancer cell lines 
after NaBU treatment (Fig. 6). These data suggest that the Hh signaling pathway 
is enhanced during gastric cancer cell differentiation. 
A. (a)                               (b)    
 
 
 
B. (a)                            (b) 
      
 
 
 
Fig. 5. Overexpression of sonic hedgehog by sodium butyrate treatment for 48 
hours in AGS (A) and MKN-45 (B) cells.  
RT-PCR (a) and Western blot (b) for SHh were performed with β-actin as 
internal standard. SHh, sonic hedgehog; NaBU, sodium butyrate. 
SHh 
SHh 
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Fig. 6. Overexpression of glioma-associated oncogene-1 (A) and patched-1 (B) 
proteins after sodium butyrate treatment for 48 hours in AGS (a) and MKN-45 
(b) cells. Gli-1, glioma-associated oncogene-1; Ptc-1, patched-1; NaBU, sodium 
butyrate. 
4. Wnt signaling pathway in gastric cancer cell differentiation 
To evaluate the Wnt signaling pathway in gastric cancer cell differentiation, 
the expression of nuclear β-catenin proteins was assessed by Western blotting 
after sequential extraction of cytosolic and nuclear proteins from cells. NaBU 
was also treated to 2µM, because gastric cancer cells were maximally 
differentiated in 2µM of NaBU in our study. 
The expression of nuclear β-catenin decreased without a change in 
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cytoplasmic β-catenin during differentiation in both gastric cancer cell lines (Fig. 
7). These results show that the activity of Wnt signaling decreased in gastric 
cancer cell differentiation. 
A. 
 
 
 
B.  
 
 
 
Fig. 7. Decreased nuclear β-catenin expression by butyrate treatment in AGS 
(A) and MKN-45 (B) cells.  
Western blot for β-catenin was performed after sequential extraction of 
cytosolic and nuclear proteins from cells in non-ionic detergent. Lamin B1 (a 
nuclear protein) and β-actin were used as internal standard. NaBU, sodium 
butyrate 
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5. Regulation of the Wnt signaling pathway by enhanced Hh 
signaling in gastric cancer cell differentiation 
In this study, ligand-dependent Hh signal activation and Wnt signal 
suppression were found in gastric cancer cell differentiation. To examine the 
mechanism of the inverse expression patterns between Hh and Wnt signaling 
during gastric cancer cell differentiation, the expression of sFRP-1 in NaBU-
treated gastric cancer cells was analyzed. sFRP-1 is an antagonist of Wnt and a 
transcriptional target of Hh signaling. In the present study, the expression of 
sFRP-1 increased in NaBU-treated cancer cells according to RT-PCR and 
Western blotting (Fig. 8). Furthermore, as shown in Figure 9, Gli-1 regulated 
the expression of sFRP-1. Ectopically over-expressed Gli-1 increased sFRP-1 
transcription and expression. When NaBU was added, over-expressed Gli-1 also 
increased sFRP-1 transcription and expression. Thus, maximal expression of 
sFRP-1 was found when Gli-1 was increased by the vector and butyrate. Chip 
assay was next performed to assess whether Gli-1, increased by the vector or 
NaBU, was involved in binding the sFRP-1 promoter. As shown in Figure 10, 
the regulation by Gli-1 involved direct binding to the sFRP-1 promoter. 
Over-expression of sFRP-1 after NaBU treatment was abolished by a siRNA 
against Gli-1 (Fig. 11). 
     To test whether increased Gli-1 expression could decrease Wnt signaling, 
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western blotting was used to analyze the nuclear pools of β-catenin after Gli-1 
over-expression by the vector or NaBU treatment. Ectopically over-expressed 
Gli-1 (by vector) decreased nuclear β-catenin protein (Fig. 12A). When sodium 
butyrate was added, the increased Gli-1 due to Hh signal activation also reduced 
the nuclear β-catenin protein (Fig. 12A). Thus, nuclear β-catenin decreased the 
most when Gli-1 was over-expressed by the vector and sodium butyrate 
treatment (Fig. 12A).  In addition, when the Topflash or Fopflash reporter 
assay was performed, TCF activity had been decreased in transfected AGS cells 
with the Gli-1 expression plasmid (Fig. 12B). When Gli-1 was suppressed by 
siRNA, the decreased nuclear β-catenin by NaBU recovered (Fig. 13). These 
findings suggest that increased Gli-1, via activated Hh signaling, in 
differentiated gastric cancer cells suppressed the Wnt signaling pathway through 
sFRP-1 over-expression.  
To validate the inverse correlation between Hh and Wnt signal pathways, 
western blotting was used to evaluate the Hh signal changes after β-catenin 
over-expression by the vector during gastric cancer cell differentiation. 
Increased Gli-1 protein by sodium butyrate was decreased after β-catenin over-
expression by the vector (Fig. 14).  
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Fig. 8. Overexpression of secreted frizzled-related protein-1 by sodium butyrate 
treatment for 48 hours in AGS (A) and MKN-45 (B) cells.  
RT-PCR (a) and Western blot (b) for sFRP-1 were performed with β-actin as 
internal standard. sFRP-1, secreted frizzled-related protein-1; NaBU, sodium 
butyrate. 
A.                                 B.              
 
 
 
 
 
Fig. 9. Glioma-associated oncogene-1 regulates the expression of secreted 
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frizzled-related protein-1.  
Increased Gli-1 expression by Gli-1 vector or 2 µM sodium butyrate increased 
the expression of sFRP-1 in RT-PCR (A) and western blot (B). The maximal 
expression of sFRP-1 was found when Gli-1 was overexpressed by vector and 
butyrate. Gli-1, glioma-associated oncogene-1; sFRP-1, secreted frizzled-related 
protein-1; NaBU, sodium butyrate. 
 
 
 
 
 
 
Fig. 10. Chromatin immunoprecipitation analysis of secreted frizzled-related 
protein-1 promoter region in AGS cells.  
Overexpressed Gli-1 by NaBU or Gli-1 vector was direct binding to the sFRP-1 
promoter region. Mouse IgG was used as the negative control and anti-RNA 
polymerase beads were used as the positive control. Gli-1, glioma-associated 
oncogene-1; sFRP-1, secreted frizzled-related protein-1; NaBU, sodium 
butyrate. 
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Fig. 11. Decreased expression of secreted frizzled-related protein-1 by siRNA 
against glioma-associated oncogene-1.  
The increased expression of sFRP-1 by Hh signal activation after NaBU 
treatment was much decreased by siRNA against Gli-1 in RT-PCR (A) and 
western blot (B). Gli-1, glioma-associated oncogene-1; sFRP-1, secreted 
frizzled-related protein-1; NaBU, sodium butyrate. 
A.  
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Fig. 12. Overexpressed glioma-associated oncogene-1 suppressed nuclear β-
catenin in AGS cells.  
A. Western blot for β-catenin was performed after sequential extraction of 
cytosolic and nuclear proteins from cells in non-ionic detergent. Lamin B1 (a 
nuclear protein) and β-actin were used as internal standard. Increased Gli-1 
expression by Gli-1 vector or NaBU decreased nuclear β-catenin proteins. The 
most decreased nuclear β-catenin proteins were found when Gli-1 was 
overexpressed by vector and NaBU. B. AGS cells were transfected with 
Topflash or Fopflash, a control, and the indicated amount of a Gli-1 vector. 
Transfection with Gli-1 vector decreased TCF activity compared with control 
(Bars, s.d.; * vs. control, p=0.044; ** vs. control, p<0.001).  
Gli-1, glioma-associated oncogene-1; NaBU, sodium butyrate. 
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Fig. 13. Decreased nuclear β-catenin after sodium butyrate treatment was 
recovered by siRNA against glioma-associated oncogene-1 in AGS cells. 
Gli-1, glioma-associated oncogene-1; NaBU, sodium butyrate. 
A.                              B. 
  
 
 
 
Fig. 14. Increased expression of glioma-associated oncogene-1 by sodium 
butyrate treatment was decreased after β-catenin over-expression by the vector 
in MKN-45 cells in RT-PCR (A) and western blot (B). 
β-actin was used for internal control. Gli-1, glioma-associated oncogene-1; 
NaBU, sodium butyrate. 
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IV. DISCUSSION 
 
Several histopathological classifications of gastric cancers exist, such as the 
WHO, Lauren, Ming, and Japanese systems. These classifications divide gastric 
cancers based on histopathological morphology. However, these classifications 
can largely be simplified to two growth patterns. One involves more gland 
formation-like growth, and the other involves less gland formation-like growth. 
Generally, the more gland formation growth pattern is believed to have a less 
aggressive biological behavior. Thus, the clinical therapeutic approach is 
different according to the histological type. For example, local endoscopic 
treatment is not generally accepted in undifferentiated-type gastric cancers 
because undifferentiated-type gastric cancer has more lymph node metastasis 
compared to differentiated-type gastric cancer. The different growth patterns of 
gastric cancer may involve different predominant molecular signaling pathways, 
especially based on cancer-initiating cell theory.5  
     Indeed, several studies have sought to analyze signaling changes 
according to histological classification in human gastric cancer tissues. These 
studies, however, have shown inconsistent results.16, 18-20 These discrepancies 
may be the result of the different extents of cancer progression or migration in 
the studies, and/or failure to take into account the interaction(s) between 
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signaling pathways. Thus, two signaling pathways, Hh and Wnt signals, in 
gastric cancer cells in vitro were investigated to examine changes purely 
according to histological differentiation, minimizing the effect of different 
cancer stages. An in vitro differentiation model of human gastric cancer cell 
lines is similar to that used in colon cancer studies.22, 29, 32, 33 This in vitro 
differentiation model of gastric cancer cell lines may reflect the molecular 
conditions of in vivo histological differentiation, based on previous 
biomorphological and molecular studies.22, 30, 31, 34 When evaluating 
morphological changes after applying differentiation-inducing agents under 
electron microscopy, numerous microvilli, more desmosomes with tightly 
cohesive clusters, and intercellular lumens along cell junctions were observed, 
mimicking primitive gland formation.22 In addition, when cancer cells were 
heterotransplanted into SCID mice with or without differentiation-inducing 
agents, the tumor originating from gastric cancer cells grown in the presence of 
the differentiation-inducing agent showed numerous well developed gland 
formations, the lumina of which were lined by many microvilli and filled with 
secretions.22 These results suggest that gastric cancer cells treated with 
differentiation-inducing agents may have the characteristics of the gland 
formation growth pattern, as seen in histopathologically differentiated-type 
gastric cancers in vivo. Furthermore, several studies have revealed that 
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molecular markers for cancer cell differentiation, by inducing agents in vitro, 
such as ALP or Brm, were correlated with histological differentiated-type 
gastric cancer tissues.30, 31, 34 The expression of one of the ALP isoenzymes was 
stronger in well differentiated than in poorly differentiated gastric carcinomas.31 
Brm is also an important factor for determining the differentiation status of 
gastric cancers.30 A tendency toward a Brm decrease was more prominent in 
poorly differentiated than in well differentiated gastric cancers.30 This study also 
showed increased ALP and Brm expression during gastric cancer cell 
differentiation by NaBU. 
     These findings suggest that ligand-dependent Hh signal activation and 
inverse Wnt signal suppression by Hh signaling occurred in gastric cancer cell 
differentiation. These results also suggest that the Hh signal pathway may be 
activated predominantly in gastric cancer tissues that have a more gland 
formation-like growth pattern. In contrast, the Wnt signaling pathway may be 
activated predominantly in gastric cancer tissues that have a less gland 
formation-like growth pattern. Immunohistochemical analysis of gastric cancer 
specimens in our study showed stronger expression of Hh signaling in well 
differentiated than in poorly differentiated cancer tissues.  
Immunohistochemistry on specimens was performed limited to stages I and II 
gastric cancer to exclude any effect of cancer stage on the signals. These 
 34 
consistent results between gastric cancer cells and human tissues may suggest 
that variable cancer stages could have caused the inconsistent results in previous 
studies.16, 18-20  
     According to this study, the inverse correlation between Hh and Wnt 
signaling was the result of sFRP-1, acting through Gli-1. Gli-1 bound directly to 
the  sFRP-1 promoter region, consistent with the results of He et al.23 However, 
Yanai et al. reported a different result because the promoter region of the 
sFRP-1 gene was methylated in AGS cells.18 Thus, siRNA against Gli-1 was 
used to investigate whether over-expression of sFRP-1 in gastric cancer cell 
differentiation was derived from demethylation by a differentiation-inducing 
agent, not by Gli-1 binding to sFRP-1. When Gli-1 was suppressed by siRNA, 
sFRP-1 was also suppressed, regardless of NaBU treatment. It was also showed 
that Gli-1 was directly bound to the sFRP-1 promoter region based on the Chip 
assay. These results suggest that the transcription of sFRP-1 was increased by 
Gli-1 binding to the sFRP-1 promoter region during gastric cancer cell 
differentiation. Increased expression of sFRP-1 then suppressed the Wnt 
signaling pathway. That is, cross talk between the Hh and Wnt signal pathways 
occurred in gastric cancer cell differentiation. 
     The present study suggests that the predominant signaling pathway may 
be dissimilar in diverse differentiation-type gastric cancers. However, variable 
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signaling pathways may be involved in clinically presenting gastric cancers, 
such as signals related to carcinogenesis, progression, and migration. Despite 
that, the existence of baseline signals related to carcinogenesis in differentiated-
type or undifferentiated-type gastric cancers may be important in the 
investigation of signaling pathways related to progression or migration.  
 
V. CONCLUSION 
 
The aim of this study was to investigate the differentiation-specific signal 
changes between Hh and Wnt pathways in gastric cancer cells. The present 
study revealed these findings. 
1. During gastric cancer cells differentiation, activation of the Hh pathway and 
suppression of the Wnt pathway occurred. 
2. The inverse correlation between Hh and Wnt pathway during differentiation 
was originated from crosstalk between Gli-1 and β-catenin though the sFRP-1. 
3. Hh signal positive immunoexpression was higher in well differentiated than 
poorly differentiated tissues. However, nuclear β-catenin-positive 
immunoexpression was lower in well differentiated compared to poorly 
differentiated tissues.  
In conclusion, the activation of the Hh pathway and suppression of the Wnt 
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pathway by Hh signaling occurred during gastric cancer cell differentiation. If 
these differentiation-specific signal changes are analyzed combined with signals 
related to the process of tumor progression or migration, it may give a clue in 
discovering the molecular heterogeneity of gastric cancers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 37 
V. REFERENCES 
 
1. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. 
Oncogene 2004;23:7274-82. 
2. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev 
Oncol Hematol 2004;51:1-28. 
3. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell 
renewal in carcinogenesis. Nature 2004;432:324-31. 
4. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: 
migrating cancer stem cells - an integrated concept of malignant tumour 
progression. Nat Rev Cancer 2005;5:744-9. 
5. Mimeault M, Batra SK. Interplay of distinct growth factors during 
epithelial mesenchymal transition of cancer progenitor cells and molecular 
targeting as novel cancer therapies. Ann Oncol 2007;18:1605-19. 
6. Taipale J, Beachy PA. The Hedgehog and Wnt signalling pathways in 
cancer. Nature 2001;411:349-54. 
7. Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, Evers BM, et al. 
Frequent activation of the hedgehog pathway in advanced gastric 
adenocarcinomas. Carcinogenesis 2005;26:1698-705. 
8. Fukaya M, Isohata N, Ohta H, Aoyagi K, Ochiya T, Saeki N, et al. 
Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. 
Gastroenterology 2006;131:14-29. 
9. Yanai K, Nagai S, Wada J, Yamanaka N, Nakamura M, Torata N, et al. 
Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J 
Surg Oncol 2007;95:55-62. 
10. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Kato Y, et al. The 
APC gene, responsible for familial adenomatous polyposis, is mutated in human 
gastric cancer. Cancer Res 1992;52:3231-3. 
11. Sasaki Y, Morimoto I, Kusano M, Hosokawa M, Itoh F, Yanagihara K, 
 38 
et al. Mutational analysis of the beta-catenin gene in gastric carcinomas. 
Tumour Biol 2001;22:123-30. 
12. Tong JH, To KF, Ng EK, Lau JY, Lee TL, Lo KW, et al. Somatic beta-
catenin mutation in gastric carcinoma--an infrequent event that is not specific 
for microsatellite instability. Cancer Lett 2001;163:125-30. 
13. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-
Preiser C, et al. beta-Catenin mutation is a frequent cause of Wnt pathway 
activation in gastric cancer. Cancer Res 2002;62:3503-6. 
14. Yuasa Y. Control of gut differentiation and intestinal-type gastric 
carcinogenesis. Nat Rev Cancer 2003;3:592-600. 
15. Tamura G. Alterations of tumor suppressor and tumor-related genes in 
the development and progression of gastric cancer. World J Gastroenterol 
2006;12:192-8. 
16. Miyazawa K, Iwaya K, Kuroda M, Harada M, Serizawa H, Koyanagi 
Y, et al. Nuclear accumulation of beta-catenin in intestinal-type gastric 
carcinoma: correlation with early tumor invasion. Virchows Arch 
2000;437:508-13. 
17. Grabsch H, Takeno S, Noguchi T, Hommel G, Gabbert HE, Mueller W. 
Different patterns of beta-catenin expression in gastric carcinomas: relationship 
with clinicopathological parameters and prognostic outcome. Histopathology 
2001;39:141-9. 
18. Yanai K, Nakamura M, Akiyoshi T, Nagai S, Wada J, Koga K, et al. 
Crosstalk of hedgehog and Wnt pathways in gastric cancer. Cancer Lett 
2008;263:145-56. 
19. Wang LH, Choi YL, Hua XY, Shin YK, Song YJ, Youn SJ, et al. 
Increased expression of sonic hedgehog and altered methylation of its promoter 
region in gastric cancer and its related lesions. Mod Pathol 2006;19:675-83. 
20. Kim B, Koo H, Yang S, Bang S, Jung Y, Kim Y, et al. TC1(C8orf4) 
correlates with Wnt/beta-catenin target genes and aggressive biological 
behavior in gastric cancer. Clin Cancer Res 2006;12:3541-8. 
 39 
21. Nakamura T, Yao T, Kabashima A, Nishiyama K, Maehara Y, 
Tsuneyoshi M. Loss of phenotypic expression is related to tumour progression 
in early gastric differentiated adenocarcinoma. Histopathology 2005;47:357-67. 
22. Choe G, Kim WH, Park JG, Kim YI. Effect of suramin on 
differentiation of human stomach cancer cell lines. J Korean Med Sci 
1997;12:433-42. 
23. He J, Sheng T, Stelter AA, Li C, Zhang X, Sinha M, et al. Suppressing 
Wnt signaling by the hedgehog pathway through sFRP-1. J Biol Chem 
2006;281:35598-602. 
24. Li X, Deng W, Lobo-Ruppert SM, Ruppert JM. Gli1 acts through Snail 
and E-cadherin to promote nuclear signaling by beta-catenin. Oncogene 
2007;26:4489-98. 
25. Maeda O, Kondo M, Fujita T, Usami N, Fukui T, Shimokata K, et al. 
Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer 
cells. Oncol Rep 2006;16:91-6. 
26. Nakashima H, Nakamura M, Yamaguchi H, Yamanaka N, Akiyoshi T, 
Koga K, et al. Nuclear factor-kappaB contributes to hedgehog signaling 
pathway activation through sonic hedgehog induction in pancreatic cancer. 
Cancer Res 2006;66:7041-9. 
27. Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, Ooya K. 
PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in 
odontogenic keratocysts. Int J Oral Maxillofac Surg 2004;33:584-92. 
28. Buras RR, Shabahang M, Davoodi F, Schumaker LM, Cullen KJ, 
Byers S, et al. The effect of extracellular calcium on colonocytes: evidence for 
differential responsiveness based upon degree of cell differentiation. Cell Prolif 
1995;28:245-62. 
29. Ribiczey P, Tordai A, Andrikovics H, Filoteo AG, Penniston JT, Enouf 
J, et al. Isoform-specific up-regulation of plasma membrane Ca2+ATPase 
expression during colon and gastric cancer cell differentiation. Cell Calcium 
2007;42:590-605. 
 40 
30. Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani 
T, Watanabe H, et al. Frequent loss of Brm expression in gastric cancer 
correlates with histologic features and differentiation state. Cancer Res 
2007;67:10727-35. 
31. Watanabe H, Tokuyama H, Ohta H, Satomura Y, Okai T, Ooi A, et al. 
Expression of placental alkaline phosphatase in gastric and colorectal cancers. 
An immunohistochemical study using the prepared monoclonal antibody. 
Cancer 1990;66:2575-82. 
32. Hung MW, Tsai LC, Lin YL, Chen YH, Chang GG, Chang TC. 
Differential regulation of placental and germ cell alkaline phosphatases by 
glucocorticoid and sodium butyrate in human gastric carcinoma cell line TMK-
1. Arch Biochem Biophys 2001;388:45-54. 
33. Gelebart P, Kovacs T, Brouland JP, van Gorp R, Grossmann J, Rivard 
N, et al. Expression of endomembrane calcium pumps in colon and gastric 
cancer cells. Induction of SERCA3 expression during differentiation. J Biol 
Chem 2002;277:26310-20. 
34. Itoh T, Miyake K, Iijima S. Differentiation-specific expression of 
chromatin remodeling factor BRM. Biochem Biophys Res Commun 
2008;366:827-33. 
 
 
 
 
 
 
 
 41 
< ABSTRACT(IN KOREAN)> 
위암세포 분화와 관련된 Hedgehog과 Wnt 신호전달의 상호작용 
 
<지도교수 이 용 찬> 
 
연세대학교 대학원 의학과 
 
김 지 현 
 
위암은 조직학적 형태에 따라 다른 생물학적 행태를 가지고 
있다고 알려져 있으며, 다른 생물학적 행태에 대한 차별적 
신호전달체계가 존재할 수 있다. 본 연구의 목적은 위암 
세포에서 조직학적 분화도에 따른 Hedgehog (Hh)과 Wnt 
신호전달의 차이를 분석하고자 하였다. 위암세포주로 AGS, 
MKN-45를 사용하였으며, 실험실적 분화에 대한 양적 
대조군으로 대장암 세포주인 HT-29를 사용하였다. 암세포의 
분화는 sodium butyrate와 all-trans retinoid acid로 유도하였다. Hh 
신호분석을 위하여 sonic hedgehog (SHh), Patched (Ptc)-1, glioma-
associated oncogene (Gli)-1을 측정하였으며, Wnt 신호분석을 
위하여 핵내 β-catenin을 측정하였다. 위암환자들의 파라핀 
조직을 통하여 생체조직의 Hh과 Wnt 신호전달을 분석하였고, 
Hh과 Wnt 신호전달의 상호작용은 secreted frizzled-related protein 
(sFRP-1)으로 분석하였다. 위암세포도 대장암세포와 비슷한 
양상으로 실험실적 분화가 유도되었는데, 분화되는 동안 
Hh신호전달은 활성화되었으나, Wnt 신호전달은 억제되는 양상을 
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보였다. Gli-1을 과발현 시켰을 때 sFRP-1의 전사가 
증가하였으며, Gli-1를 억제하였을 때에는 sFRP-1의 전사가 
감소하였고, 이는 chromatin immunoprecipitation (Chip) assay를 
통하여 Gli-1이 sFRP-1의 전사를 조절함을 알 수 있었다. Wnt 
신호전달에 있어서는 Gli-1의 과발현시 핵내 β-catenin 발현이 
감소하였으나, Gli-1을 억제하였을 때 핵내 β-catenin 발현이 
회복되었다. 위암환자 조직에서 시행한 면역화학염색에서는 SHh, 
Gli-1 단백이 고분화 선암에서 저분화 선암보다 강하게 
발현되었으며, 핵내 β-catenin 단백은 저분화 선암에서 고분화 
선암보다 강하게 발현되었다. 결론적으로 위암세포가 분화하는 
동안 Hh신호전달은 활성화되고 Wnt신호전달은 억제되었다. 
이와 같이 분화 특이 신호전달변화가 암의 진행이나 전이와 
관련된 신호전달과 같이 분석이 된다면 위암의 분자생물학적 
이질성을 이해하는 데에 도움이 될 것이다. 
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